SCHEMBL21600994

SCHEMBL21600994

C=CC(=O)Nc1cc(N2CCC(N(C)C)CC2)c(F)cc1Nc1ncc(C#N)c(-c2c[nH]c3ccccc23)n1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CDK7 P50613 3/20 0.54
▸ CCNH P51946 3/20 0.54
▸ MNAT1 P51948 2/20 0.54
▸ CCNT1 O60563 2/20 0.54
▸ CCNA2 P20248 2/20 0.54
▸ CDK2 P24941 2/20 0.54
▸ CDK9 P50750 2/20 0.54
▸ EGFR P00533 16/20 0.53
▸ CDK1 P06493 1/20 0.49
▸ CCNB1 P14635 1/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ IGF1R P08069 3/20 0.47
▸ KCNH2 Q12809 3/20 0.47
▸ CCNK O75909 1/20 0.46
▸ CDK13 Q14004 1/20 0.46
▸ CDK12 Q9NYV4 1/20 0.46
▸ CDK5 Q00535 1/20 0.46
▸ CDK5R1 Q15078 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21600992 0.93 EGFR (0.53) CDK7CCNHMNAT1CCNT1CCNA2
SCHEMBL21600990 0.92 EGFR (0.57) CDK7CCNHMNAT1CCNT1CCNA2
SCHEMBL21601031 0.90 EGFR (0.62) CDK7CCNHMNAT1CCNT1CCNA2
SCHEMBL21601034 0.90 CDK7 (0.54) CDK7CCNHMNAT1CCNT1CCNA2
SCHEMBL21600996 0.89 CDK7 (0.53) CDK7CCNHMNAT1CCNT1CCNA2
SCHEMBL28537409 0.89 EGFR (0.58) CDK7CCNHMNAT1CCNT1CCNA2
SCHEMBL21601000 0.89 EGFR (0.54) CDK7CCNHMNAT1CCNT1CCNA2
SCHEMBL19467707 0.85 EGFR (0.65) CDK7CCNHMNAT1CCNT1CCNA2
SCHEMBL21600993 0.81 EGFR (0.54) CDK7CCNHMNAT1CCNT1CCNA2
SCHEMBL25140005 0.80 PLK1 (0.50) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019242689-A1 CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2019-12-26 — — WO disclosed
Send feedback